bluebird bio acquires Durham manufacturing facility for $11.5M

bluebird bio acquired a 125,000-square-foot manufacturing facility in Durham, North Carolina, for $11.5 million to produce lentiviral vectors for its cell and gene therapies.

“Investing in a world-class manufacturing infrastructure is a crucial step in accomplishing that mission on behalf of the people who need these novel treatments.”genengnews.com

• 1 source
• genengnews.combluebird bio Acquires Durham, NC, Manufacturing Site for Lentiviral Vector ProductionAlex PhilippidisNov 29, 2017

Summarized from public sources; check the original articles before acting on it.